<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02761928</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-15-0809</org_study_id>
    <nct_id>NCT02761928</nct_id>
  </id_info>
  <brief_title>Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients</brief_title>
  <acronym>Hypermoble</acronym>
  <official_title>Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study of axial spine pain and hyperflexibility. Patients will receive physical
      exam maneuvers (traditional straight leg raise, FABER, facet loading as well as Beighton's
      hypermobility score) and blood / urine / saliva collection. They will also be separated into
      pain groups based on their response to injections. A correlation between exam findings and
      procedure group will be measured.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study of patients with neck and back pain followed by a pain
      management clinic. Patients with particular pain generators in the neck and back will be
      defined by a positive response to one of several targeted interventional pain procedures.
      Each patient may undergo a physical exam to determine whether they have hypermobile joints.
      The study will thus evaluate the rate of hypermobility for each pain generator. In addition
      blood, urine, or saliva samples may be taken for biomarkers for pain or rheumatologic
      factors.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Beighton hypermobility score</measure>
    <time_frame>Prior to injection (2 weeks prior to injection for each patient)</time_frame>
    <description>9 point standardized scale</description>
  </primary_outcome>
  <number_of_groups>10</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Low Back Pain, Mechanical</condition>
  <condition>Spinal Stenosis</condition>
  <condition>Nerve Root Disorder</condition>
  <condition>Radiculopathy, Cervical</condition>
  <condition>Benign Hypermobility Syndrome</condition>
  <arm_group>
    <arm_group_label>Epidural</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to any epidural (e.g. interlaminar/paramedian, transforaminal, caudal)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Selective nerve root block</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to selective nerve root block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Facet injection</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to intra-articular facet injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medial branch block</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to median branch nerve block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medial branch RFA</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to median branch nerve radiofrequency ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SIJ injection</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to sacroiliac joint injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lateral branch block</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to lateral branch nerve block for SIJ</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Greater trochanter injection</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to greater trochanteric bursa injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Piriformis injection</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to piriformis injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trigger point injection</arm_group_label>
    <description>Positive response (&gt;50% pain relief) to trigger point injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Beighton score for hypermobility</intervention_name>
    <description>The beighton score is a 9 point score of flexibility, used for patients with disorders of collagen.</description>
    <arm_group_label>Epidural</arm_group_label>
    <arm_group_label>Selective nerve root block</arm_group_label>
    <arm_group_label>Facet injection</arm_group_label>
    <arm_group_label>Medial branch block</arm_group_label>
    <arm_group_label>Medial branch RFA</arm_group_label>
    <arm_group_label>SIJ injection</arm_group_label>
    <arm_group_label>Lateral branch block</arm_group_label>
    <arm_group_label>Greater trochanter injection</arm_group_label>
    <arm_group_label>Piriformis injection</arm_group_label>
    <arm_group_label>Trigger point injection</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, urine, saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with low back pain who are determined to be candidates for a pain procedure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of axial back pain (neck, mid-back, lower back) or pain radiating
             to the extremity, with suspected diagnosis of a specific pain generator amenable to a
             pain procedure, including disorders of the nerves, joints, and muscles as listed
             immediately below.

          -  Clinical decision to schedule patient for a pain procedure, including procedures
             targeting the following disorders:

               -  Facet arthropathy: intra-articular facet joint injection, medial branch block,
                  medial branch radiofrequency ablation

               -  Sacroiliac joint dysfunction: sacroiliac joint injection, lateral branch block,
                  lateral branch radiofrequency ablation

               -  Myofascial pain syndrome: trigger point injection

               -  Radiculopathy, spinal stenosis, or herniated nucleus pulposus: epidural steroid
                  injection, selective nerve root block

               -  Piriformis syndrome: piriformis injection

               -  Greater trochanteric bursitis: greater trochanteric bursa injection

          -  Able to provide HIPAA authorization to share prior medical records/imaging.

        Exclusion Criteria:

          -  Previous diagnosis of cancer.

          -  Currently pregnant.

          -  Previously enrolled for the same procedure or the same pain generator site. (For
             example, this would exclude a patient who had an intra-articular facet joint injection
             at the right L5/S1 if: 1) he had the same injection 3 months ago and was enrolled at
             that time, or 2) the patient was already enrolled for a medial branch block at the
             right L5 and sacral ala, as this targets the same facet joint.)

          -  Inability or unwillingness of subject or legal guardian/representative to give
             informed consent (e.g., ward of the state)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Burish, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Grahame R. Joint hypermobility syndrome pain. Curr Pain Headache Rep. 2009 Dec;13(6):427-33. Review.</citation>
    <PMID>19889283</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2016</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Mark J Burish</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Facet Joint</keyword>
  <keyword>Sacroiliac Joint</keyword>
  <keyword>Myofascial Trigger Point Pain</keyword>
  <keyword>Injectables</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Radiculopathy</mesh_term>
    <mesh_term>Ehlers-Danlos Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

